샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793705

세계의 말초 스텐트 임플란트 시장

Peripheral Stent Implants
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 369 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말초 스텐트 임플란트 세계 시장은 2030년까지 56억 달러에 달할 전망

2024년에 40억 달러로 추정되는 말초 스텐트 임플란트 세계 시장은 2024년부터 2030년까지 CAGR 6.0%로 성장하여 2030년에는 56억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 일반 금속 스텐트는 CAGR 6.8%를 기록하며 분석 기간 종료까지 33억 달러에 달할 것으로 예측됩니다. 커버드 스텐트 부문의 성장률은 분석 기간 동안 CAGR 5.2%로 추정됩니다.

미국 시장은 11억 달러로 추정, 중국은 CAGR 9.6%로 성장 예측

미국의 말초 스텐트 임플란트 시장은 2024년에 11억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 12억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.9%와 5.9%로 예측됩니다. 유럽에서는 독일이 CAGR 3.9%로 성장할 것으로 예측됩니다.

세계의 말초 스텐트 임플란트 시장 - 주요 동향과 촉진요인 정리

왜 말초 스텐트 임플란트가 동맥 질환의 혈류 회복에 필수적인가?

말초 스텐트 임플란트는 특히 말초동맥질환(PAD)의 경우, 사지의 좁아지거나 막힌 동맥을 뚫어주는데 사용되는 의료기기입니다. 이 스텐트는 혈관의 개통을 유지하고 혈액 순환을 회복하며, 조직 허혈이나 절단과 같은 합병증을 예방하기 위해 구조적 지지력을 제공합니다. 스텐트는 카테터를 이용한 시술로 삽입되며, 외과적 우회술을 대체할 수 있는 최소침습적 치료법을 제공합니다.

PAD는 당뇨병, 흡연, 노화와 밀접한 관련이 있기 때문에 스텐트삽입술은 혈관 의료의 핵심적인 치료법으로 자리 잡았습니다. 스텐트는 대퇴 슬와 동맥과 장골 동맥의 폐색 치료에서 특히 중요하며, 기존의 혈관성형술로는 장기적인 개통을 얻지 못할 수 있습니다. 스텐트 설계 및 배치 기술의 지속적인 개선으로 내구성과 환자 예후가 개선되고 있습니다.

효능과 안전성을 향상시키는 기술은 어떻게 발전하고 있는가?

스텐트의 기술 혁신은 재협착과 파열을 최소화하면서 반경 방향의 강도, 유연성, 장기 개통성을 높이는 데 초점을 맞추고 있습니다. 니티놀 기반 자가 확장형 스텐트는 그 움직임과 혈관 압박에 대한 적응성으로 인해 말초혈관에 널리 사용되고 있습니다. 약물 용출 스텐트(DES)와 약물 코팅 스텐트(DCS)는 파클리탁셀과 같은 항증식제를 방출하여 재협착의 위험을 감소시킵니다.

생체흡수성 스텐트는 아직 평가 중이지만, 장기적인 합병증을 줄이면서 일시적인 발판을 마련할 수 있는 가능성이 있습니다. 개선된 스텐트 전달 시스템, 얇은 카테터, 영상 보조 배치 도구는 시술의 정확성을 높였습니다. 또한, 무릎 아래(BTK) 동맥과 같은 고난이도 해부학에 맞게 특별히 설계된 새로운 스텐트가 치료 적응증 확대를 뒷받침하고 있습니다.

시장 성장은 어디에 집중되어 있으며, 어떤 상황이 채용을 촉진하고 있는가?

첨단 헬스케어 시스템의 혈관외과 센터, 카테터 검사실, 중재적 방사선과에서 가장 많이 개발되고 있습니다. 북미와 유럽은 PAD 스크리닝과 인터벤션 인프라가 잘 구축되어 있어 시술 건수에서 선두를 달리고 있습니다. 아시아태평양은 고령화, 당뇨병 유병률 증가, 혈관 치료 접근성 향상 등을 배경으로 스텐트 치료가 급증하고 있습니다.

스텐트 삽입의 주요 촉진요인으로는 간헐적 파행, 중증 허혈성 사지, 만성 완전 폐색 등을 들 수 있습니다. 스텐트 삽입술이 보다 간소화되고 자원 집약적이지 않게 됨에 따라, 외래 수술 센터 및 외래 수술 센터에서의 장치 채택이 확대되고 있습니다. 초기 단계의 PAD 관리 전략에도 스텐트가 도입되어 기능적 결과를 개선하고 중증 허혈성 사지로의 진행을 예방하고 있습니다.

말초 스텐트 임플란트 시장의 성장은 몇 가지 요인에 의해 주도됩니다...

말초 스텐트 임플란트 시장의 성장은 말초동맥질환의 유병률 증가, 스텐트 재료 및 디자인의 발전, 최소침습적 혈관 중재술에 대한 선호도 증가 등의 요인으로 인해 발생할 수 있습니다. 약물 용출 스텐트 및 자가 확장형 스텐트의 임상적 사용 확대는 장기적인 결과를 개선하고 보다 광범위한 시술의 채택을 뒷받침하고 있습니다.

스텐트의 가시성, 유연성, 혈역학과의 적합성 향상으로 시술의 안전성을 높였습니다. 외래 혈관내 치료에 대한 투자 증가, 지원적인 상환 정책, 중재시술 전문가 양성 등이 시장 확대를 더욱 촉진하고 있습니다. 인구 고령화와 혈관 위험인자의 증가로 말초 스텐트 삽입술은 여전히 전 세계 PAD 치료 전략의 핵심으로 자리 잡고 있습니다.

부문

제품(일반 금속 스텐트, 피복 스텐트, 약물 용출 스텐트), 최종사용자(병원 최종사용자, 외래 수술 센터/외래 최종사용자), 동맥(경동맥 스텐트, Fem-Pop 동맥 스텐트, 장골동맥 스텐트, Infrapop 동맥 스텐트)

조사 대상 기업 사례

  • Abbott
  • Admedes GmbH
  • Alvimedica
  • B. Braun Melsungen AG
  • Bentley InnoMed GmbH
  • Biotronik
  • Boston Scientific
  • Cardinal Health
  • Cook Medical
  • Cordis
  • Endologix LLC
  • Gore Medical(W. L. Gore)
  • iVascular
  • JOTEC GmbH(CryoLife)
  • Medinol
  • Medtronic
  • MicroPort Scientific
  • SMT(Sahajanand Medical Tech)
  • Terumo Corporation
  • Translumina Therapeutics

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.26

Global Peripheral Stent Implants Market to Reach US$5.6 Billion by 2030

The global market for Peripheral Stent Implants estimated at US$4.0 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Bare Metal Stents, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Covered Stents segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 9.6% CAGR

The Peripheral Stent Implants market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Peripheral Stent Implants Market - Key Trends & Drivers Summarized

Why Are Peripheral Stent Implants Critical in Restoring Blood Flow in Arterial Disease?

Peripheral stent implants are medical devices used to open narrowed or blocked arteries in the limbs, particularly in cases of peripheral artery disease (PAD). These stents provide structural support to keep vessels open, restore blood circulation, and prevent complications such as tissue ischemia or amputation. They are deployed via catheter-based procedures, offering a minimally invasive alternative to surgical bypass.

PAD is strongly associated with diabetes, smoking, and aging, making stenting a central intervention in vascular medicine. Stents are particularly important in treating femoropopliteal and iliac artery blockages, where traditional angioplasty may not offer long-term patency. Continued refinement in stent design and deployment techniques is improving durability and patient outcomes.

How Are Technologies Advancing for Improved Efficacy and Safety?

Stent innovation is focused on increasing radial strength, flexibility, and long-term patency while minimizing restenosis and fracture. Nitinol-based self-expanding stents are widely used for peripheral vessels due to their adaptability to movement and vessel compression. Drug-eluting stents (DES) and drug-coated stents (DCS) release antiproliferative agents like paclitaxel to reduce the risk of re-narrowing.

Bioabsorbable stents, though still under evaluation, offer the potential for temporary scaffolding with reduced long-term complications. Improved stent delivery systems, low-profile catheters, and imaging-assisted placement tools are enhancing procedural precision. Additionally, new stents designed specifically for challenging anatomies such as below-the-knee (BTK) arteries are supporting expanded treatment indications.

Where Is Market Growth Concentrated and Which Conditions Are Driving Adoption?

Adoption is highest in vascular surgery centers, catheterization labs, and interventional radiology units across developed healthcare systems. North America and Europe lead in procedural volume due to well-established PAD screening and interventional infrastructure. Asia-Pacific is witnessing rapid growth in stent procedures driven by aging populations, increased prevalence of diabetes, and improving access to vascular care.

The primary drivers of stent implantation include intermittent claudication, critical limb ischemia, and chronic total occlusions. Device adoption is expanding in outpatient and ambulatory surgical centers as stenting procedures become more streamlined and less resource-intensive. Early-stage PAD management strategies are also incorporating stents to improve functional outcomes and prevent progression to severe limb ischemia.

Growth in the Peripheral Stent Implants market is driven by several factors…

Growth in the peripheral stent implants market is driven by factors such as rising incidence of peripheral artery disease, advancements in stent material and design, and growing preference for minimally invasive vascular interventions. Expanding clinical use of drug-eluting and self-expanding stents is improving long-term outcomes and supporting broader procedural adoption.

Improvements in stent visibility, flexibility, and compatibility with vessel dynamics are enhancing procedural safety. Increasing investments in outpatient endovascular procedures, supportive reimbursement policies, and training of interventional specialists are further fueling market expansion. As population aging and vascular risk factors continue to rise, peripheral stenting remains a cornerstone of PAD treatment strategies worldwide.

SCOPE OF STUDY:

The report analyzes the Peripheral Stent Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bare Metal Stents, Covered Stents, Drug Eluting Stents); End-Use (Hospitals End-Use, Ambulatory Surgery Centers / Outpatient End-Use); Artery (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, Infrapop Artery Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott
  • Admedes GmbH
  • Alvimedica
  • B. Braun Melsungen AG
  • Bentley InnoMed GmbH
  • Biotronik
  • Boston Scientific
  • Cardinal Health
  • Cook Medical
  • Cordis
  • Endologix LLC
  • Gore Medical (W. L. Gore)
  • iVascular
  • JOTEC GmbH (CryoLife)
  • Medinol
  • Medtronic
  • MicroPort Scientific
  • SMT (Sahajanand Medical Tech)
  • Terumo Corporation
  • Translumina Therapeutics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Stent Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Peripheral Arterial Disease (PAD) Spurs Demand for Endovascular Stent Implants
    • Growth in Minimally Invasive Interventions Throws the Spotlight on Self-Expanding and Balloon-Expandable Stent Technologies
    • OEM Innovation in Drug-Eluting and Bioabsorbable Peripheral Stents Enhances Long-Term Patency and Reduces Restenosis
    • Expansion of PAD Screening Programs and Aging Population Strengthens Procedural Volumes in Lower Limb Revascularization
    • Improved Imaging and Navigation Systems Support Accurate Stent Deployment in Complex Anatomies
    • OEM Collaboration With Vascular Surgeons Drives Innovation in Tapered and Flexible Stent Platforms
    • Surge in Demand for Below-the-Knee (BTK) and Superficial Femoral Artery (SFA) Stents Expands Device Portfolios
    • Regulatory Approvals and Favorable Clinical Outcomes Fuel Adoption of Next-Generation Peripheral Stents
    • Increased Preference for Ambulatory Vascular Procedures Supports Use of Low-Profile, Deliverable Stent Systems
    • OEM Focus on Radiopaque Markers and Scaffold Design Enhances Intraoperative Precision and Post-Procedure Monitoring
    • Integration of Stent Systems With Drug-Coated Balloons Supports Hybrid Therapy Models for High-Risk Lesions
    • Growing Use of Nitinol and Cobalt-Chromium Materials Enhances Durability and Fracture Resistance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Stent Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Stent Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Bare Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Covered Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Covered Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers / Outpatient End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fem-Pop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fem-Pop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fem-Pop Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Iliac Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Iliac Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Iliac Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Infrapop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Infrapop Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Infrapop Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • JAPAN
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • CHINA
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • EUROPE
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Peripheral Stent Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • FRANCE
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • GERMANY
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Peripheral Stent Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • INDIA
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: India 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Peripheral Stent Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Peripheral Stent Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Peripheral Stent Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030
  • AFRICA
    • Peripheral Stent Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Peripheral Stent Implants by Product - Bare Metal Stents, Covered Stents and Drug Eluting Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Peripheral Stent Implants by Product - Percentage Breakdown of Value Sales for Bare Metal Stents, Covered Stents and Drug Eluting Stents for the Years 2014, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Peripheral Stent Implants by End-Use - Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Peripheral Stent Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Surgery Centers / Outpatient End-Use for the Years 2014, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Peripheral Stent Implants by Artery - Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Peripheral Stent Implants by Artery - Percentage Breakdown of Value Sales for Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents and Infrapop Artery Stents for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제